FTC "unfairness" standard
This article was originally published in The Tan Sheet
Executive Summary
Nonprescription Drug Manufacturers Association is part of a 36-member coalition that sent a Feb. 15 letter to all conferees working on Federal Trade Commission reauthorization legislation (HR 2243). The letter, also signed by the Cosmetic, Toiletry and Fragrance Association, urges support of "continued restrictions on the FTC's unfairness authority for advertising" and supports a Senate version of the bill, which makes permanent a ban on FTC's use of unfairness rulemaking authority for ads. The House bill places no restrictions on FTC's rulemaking authority ("The Tan Sheet" Sept. 27, 1993, In Brief)